Lexaria Bioscience Corp (LEXX) - Net Sales Margin

Graphic logo of Lexaria (LEXX)

Lexaria Bioscience develops advanced drug delivery methods, generating moderate revenue through licensing. The seamless shipment of small compound samples maintains process stability. The aggregate return on sales demonstrates revenue yield, where the -3985.60 metric determines this level. Meanwhile, the business relies on external manufacturers, fully outsourcing tablet production to third-party vendors.

lexariabioscience.com (LEXX) Net Profit Rate: for the period 07/04/2022 - 11/19/2026

LEXX (Lexaria Bioscience Corp): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
Summary company analytics:Lexaria Bioscience - LEXX
Flagship merchandise of Lexaria Bioscience Corp.

Lexaria Bioscience development of the innovative DehydraTECH platform requires significant investment in clinical trials for obesity and hypertension drugs. Sales margin measures the portion of revenue remaining as net profit after covering all operating expenses and interest payments on debt. This indicator demonstrates the efficiency of intellectual property monetization and resilience to the cost of borrowed capital. Growth in this metric would confirm the successful licensing of technologies by pharmaceutical behemoths. By analyzing the dynamics of net turnover profitability, an investor can assess the issuer's real financial autonomy.

Direct competitors

HLN: Net Sales Margin|Net Return on Sales KVUE|Net Margin veronapharma.com|Net Return on Sales MENS (Jyong Biotech Corp)|Net Margin Ligand (LGND)|Net Sales Margin amneal.com (AMRX)|Net Sales Margin PRGO (perrigo.com)|Alvotech SA (ALVO) - Net Margin|Liquidia Inc. - Net Sales Margin|Net Profitability Margin Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Net Margin|Net Return on Sales MNKD|Net Margin Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Company Sales Margin|Net Sales Margin SPRY|TBPH - Net Margin|Aquestive Pharma - Return on Sales by Net Profit|Net Sales Margin scpharmaceuticals.com SCPH|Tectonic - Net Sales Margin|TNXP - Net Sales Margin|SXTC: Net Sales Margin|Eupraxia Pharma - Net Profit Rate|BHST (bioharvest.com) - Net Sales Margin|Net Return on Sales EXOZ (invizyne.com)|Net Sales Margin ORMP|Company Sales Margin Entera Bio|Net Sales Margin HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Net Margin|Cumberland Corp - Net Sales Margin|QNTM - Net Sales Margin|FibroGen, Inc. (FGEN) - Net Margin|TELO: Company Net Profitability|RANI (Rani Therapeutics Inc) - Net Sales Margin|Net Margin synergychc.com SNYR|Net Margin Rallybio Corp. (RLYB)|PULM (Pulmatrix, Inc.) - Net Profit Rate|Pheton Holdings - Return on Sales by Net Profit|Net Sales Margin Aptorum Group Limited APM|LYRA: Return on Sales by Net Profit|IBO: Net Margin|TNFA: Net Sales Margin|YCBD: Company Net Profitability|Net Margin PainReform Ltd|CYTO (altamiratherapeutics.com) - Company Net Profitability|Net Sales Margin LIPO|OPTN - Net Margin|Net Margin pieris.com PIRS|Net Profit Rate PROC|PTPI - Net Margin|Qilian International Holding (QLI) - Return on Sales by Net Profit|SLRN: Net Sales Margin|Return on Sales by Net Profit TFF Pharma